This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
Accession | PRJNA126201; GEO: GSE21541 |
Type | Umbrella project |
Publications | Chari R et al., "An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.", BMC Syst Biol, 2010 May 17;4:67 |
Submission | Registration date: 31-Dec-2010 Wan Lam Lab, Cancer Genetics and Developmental Biology, BC Cancer Research Centre |
Relevance | Superseries |
Project Data:
Resource Name | Number of Links |
---|
Publications |
PubMed | 1 |
PMC | 1 |
Other datasets |
GEO DataSets | 5 |
GEO Data DetailsParameter | Value |
---|
Data volume, Spots | 5692898 |
Data volume, Processed Mbytes | 97 |
Data volume, Supplementary Mbytes | 610 |
This project encompasses the following 4 sub-projects:
Project Type | Number of Projects |
Epigenomics | 1 |
BioProject accession | Organism | Title |
---|
PRJNA129039 | Homo sapiens | An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer: DNA methylation (Wan Lam Lab, Cancer Genetics...) |
|
Transcriptome or Gene expression | 1 |
BioProject accession | Organism | Title |
---|
PRJNA129037 | Homo sapiens | An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer: gene expression (Wan Lam Lab, Cancer Genetics...) |
|
Variation | 2 |
BioProject accession | Organism | Title |
---|
PRJNA129507 | Homo sapiens | An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer: allelic status (Wan Lam Lab, Cancer Genetics...) | PRJNA129511 | Homo sapiens | An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer: CGH (Wan Lam Lab, Cancer Genetics...) |
|